1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, January 2016 (p9)

Biological Therapy Analysis & Statistics, January 2016 (p9)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

241-270 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Anti GM-CSF Antibody -Pipeline Insights, 2016

Anti GM-CSF Antibody -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Anti GM-CSF Antibody-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Anti GM-CSF Antibody. The ...

  • Industries : Biopharmaceutical, Biotechnology, Biological Therapy
Growth Hormone Antagonists -Pipeline Insights, 2016

Growth Hormone Antagonists -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Growth Hormone Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Antagonists. ...

  • Industries : Biological Therapy, Biopharmaceutical
Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2016

Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Interferon-Alpha/Beta Receptor Binders-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Inte ...

  • Industries : Office Supply and Stationery, Office Goods, Biopharmaceutical, Biological Therapy
Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2016

Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Hepatocyte growth factor (HGF) mimetic-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatocyte ...

  • Industries : Biological Therapy
 B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell Non-Hodgkin ...

  • Industries : Biological Therapy
Rituxan -Drug Insights, 2016

Rituxan -Drug Insights, 2016

  • $ 1 000
  • Industry report
  • January 2016
  • by Delve Insight

DelveInsight Drug Report, “Rituxan- Drug Insights, 2016” highlights the Rituxan marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe
Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2016

Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Interferon Gamma Receptor (IFNGR) Binders-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Interferon ...

  • Industries : Office Supply and Stationery, Office Goods, Biological Therapy
Herceptin -Drug Insights, 2016

Herceptin -Drug Insights, 2016

  • $ 1 000
  • Industry report
  • January 2016
  • by Delve Insight

DelveInsight Drug Report, “Herceptin- Drug Insights, 2016” highlights the Herceptin marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe
Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

  • Industries : Biological Therapy
  • Countries : World, Europe, India, China
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the ...

  • Industries : Biological Therapy
GM-CSF Inhibitors -Pipeline Insights, 2016

GM-CSF Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “GM-CSF Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the GM-CSF Inhibitors. The DelveInsight’s ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy
T Cell Inhibitors -Pipeline Insights, 2016

T Cell Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “T Cell Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the T Cell Inhibitors. The DelveInsight’s ...

  • Industries : Biological Therapy
Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor (FGF) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast ...

  • Industries : Biological Therapy
B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2016

B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “B-Cell Activating Factor (BAFF) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell ...

  • Industries : Biological Therapy
Interleukin (IL) Inhibitors -Pipeline Insights, 2016

Interleukin (IL) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Interleukin (IL) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Interleukin (IL) ...

  • Industries : Biological Therapy
Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2016

Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Chemokine Receptor Antagonists -Pipeline Insights, 2016

Chemokine Receptor Antagonists -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Chemokine Receptor Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Chemokine Recepto ...

  • Industries : Biological Therapy
 Growth Hormone Deficiency-Pipeline Insights, 2016

Growth Hormone Deficiency-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Growth Hormone Deficiency-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Deficiency. ...

  • Industries : Biological Therapy
Global Gene Therapy Market Forecast to 2020

Global Gene Therapy Market Forecast to 2020

  • $ 2 200
  • Industry report
  • January 2016
  • by RNCOS

Gene therapy is one of the most widely researched fields in the healthcare industry. The high potential of gene therapy to cure various chronic diseases makes it a popular research area. Various researches ...

  • Industries : Biological Therapy
  • Countries : World
Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2016

Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and thei ...

  • Industries : Biological Therapy
G-CSF Inhibitors -Pipeline Insights, 2016

G-CSF Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “G-CSF Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the G-CSF Inhibitors. The DelveInsight’s ...

  • Industries : Biological Therapy
Growth Hormone (GH) Agonists -Pipeline Insights, 2016

Growth Hormone (GH) Agonists -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Growth Hormone (GH) Agonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone ...

  • Industries : Biological Therapy, Biopharmaceutical
Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2016

Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and thei ...

  • Industries : Biological Therapy
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2016

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Activation Protein (FAP or Seprase) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
Notch Signaling Pathway Inhibitors -Pipeline Insights, 2016

Notch Signaling Pathway Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Notch Signaling Pathway Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Notch Signaling ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2016

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biological Therapy
Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2016

Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Fibroblast activation protein (FAP) antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
 Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016

Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hematopoietic ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.